Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Quote. Delayed Nasdaq - 09/27 04:00:00 pm
408.84 USD   -4.95%
05:08pINSIDER SELL : Moderna
MT
04:20pKraton, Hess rise; Apple, Moderna fall
AQ
03:38pMODERNA : U.S. administers 390.7 mln doses of COVID-19 vaccines - CDC
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : U.S. administers 343.4 mln doses of COVID-19 vaccines - CDC

07/28/2021 | 03:04pm EDT

July 28 (Reuters) - The United States has administered 343,361,524 doses of COVID-19 vaccines in the country as of Wednesday morning and distributed 395,974,515 doses, the U.S. Centers for Disease Control and Prevention said.

Those figures are up from the 342,607,540 vaccine doses the CDC said had gone into arms by July 27 out of 395,460,845 doses delivered.

The agency said 189,494,180 people had received at least one dose while 163,588,042 people are fully vaccinated as of Wednesday.

The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech , as well as Johnson & Johnson's one-shot vaccine as of 6:00 a.m. ET on Wednesday. (Reporting by Mrinalika Roy in Bengaluru)


ę Reuters 2021
All news about MODERNA, INC.
05:08pINSIDER SELL : Moderna
MT
04:20pKraton, Hess rise; Apple, Moderna fall
AQ
03:38pMODERNA : U.S. administers 390.7 mln doses of COVID-19 vaccines - CDC
RE
03:30pMODERNA : U.S. CDC Says Delivered 471,818,715 Doses Of Covid-19 Vaccine As Of Sept 27
RE
11:21aMODERNA : EMA Starts Review of Moderna's COVID-19 Booster Shot
MT
11:20aMODERNA : EU reviewing data on Moderna's COVID-19 booster shot
RE
11:12aMODERNA : Hy-Vee Now Offering Free Pfizer-BioNTech COVID-19 Booster Vaccines to Eligible I..
AQ
11:10aGLOBAL MARKETS LIVE : Intel, Apple, Rolls-Royce, Raytheon, MGM...
10:32aMODERNA : EU evaluating data on Moderna's COVID-19 vaccine booster dose
RE
09:30aWALL STREET STOCK EXCHANGE : A new gift from China
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 333 M - -
Net income 2021 12 514 M - -
Net cash 2021 12 947 M - -
P/E ratio 2021 13,8x
Yield 2021 -
Capitalization 165 B 165 B -
EV / Sales 2021 7,48x
EV / Sales 2022 6,77x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 408,84 $
Average target price 307,77 $
Spread / Average Target -24,7%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.311.74%173 624
LONZA GROUP AG30.56%59 611
IQVIA HOLDINGS INC.46.01%50 128
CELLTRION, INC.-25.49%31 745
SEAGEN INC.-7.88%29 353
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.83.42%23 097